# Traick

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/traick

- Industry: Software
- Headquarters: London, UK
- Website: www.traick.ai
- Total disclosed funding: $150M
- Latest round: Seed (Nov 11, 2025)
- Investors on record: 1

## About

Traick, based in London, UK, specializes in clinical decision support software using advanced AI to assess the risk of malignancy in thyroid nodules, enhancing diagnostic accuracy for healthcare professionals. Founded by co-founders Prof.Dr.Duzgun Yildirim, Prof.Dr.Aytug Altundag, Dr. Burcu Bektas Gunes and Sahmeran Arican in 2021 and headquartered in London, UK, Traick focuses on developing AI-based solutions for thyroid nodule assessment. The company has successfully completed one deal, securing USD 150 million in Seed funding from iLab Ventures as of November 2025.Traick AI specializes in clinical decision support software focused on assessing the risk of malignancy in thyroid nodules through advanced artificial intelligence. The core product utilizes AI algorithms to analyze ultrasound images, generate TIRADS scores (Thyroid Imaging Reporting and Data System), and provide risk assessments within a rapid timeframe of 10 seconds. This functionality is integrated into clinicians' workflows, allowing for the efficient detection of nodules, documentation of their characteristics, and streamlined patient follow-up. The target users of Traick include healthcare professionals such as radiologists and endocrinologists, particularly in markets such as the United Kingdom, Turkey, and the European Union, where the company is poised for expansion following CE certification.Traick AI's revenue model is rooted in a subscription-based framework for its clinical decision support software, enabling healthcare institutions to access its suite of tools for ultrasound analysis and malignancy risk assessment. This structure facilitates direct transactions with hospitals, clinics, and medical practices, where users subscribe to the software to enhance their diagnostic capabilities. Furthermore, the provision of online second opinions and real-time patient statistics access may contribute to the revenue stream, appealing to a broad base of medical professionals seeking reliable diagnostic support.In November 2025, Traick raised USD 1.50 million in Seed funding from iLab Ventures. The company plans to utilize this funding to accelerate research and development, expand clinical validation, advance regulatory certification, and support commercial expansion in Europe and the UK.

## Funding rounds

- Seed, Nov 11, 2025, $150M — iLab Ventures

## Investors

- iLab Ventures (https://capitalatlas.ai/funds/ilab-ventures) — Seed